1. Berlex Laboratories, Inc. (11 from 100 patents)

2. Metabolex, Inc. (11 from 41 patents)

3. Schering Aktiengesellschaft (7 from 1,384 patents)

4. Pharmacopeia Drug Discovery, Inc. (6 from 52 patents)

5. Cymabay Therapeutics, Inc. (5 from 43 patents)

6. Other (4 from 832,680 patents)

7. Pharmacopeia Inc. (1 from 101 patents)

8. Berlax Laboratories, Inc. (1 from 1 patent)

1. 9925189 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

2. 9737537 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

3. 8975258 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

4. 8921350 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

5. 8846675 - N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

6. 8288384 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

7. 8227495 - 2,4-disubsituted thiazoles and pharmaceutical compositions thereof

8. 8183381 - N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

9. 7714131 - Process for the stereoselective preparation of (−)-halofenate and derivatives thereof

10. 7642358 - Substituted phenylacetic acids

11. 7638541 - 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine

12. 7622491 - Modulators of PPAR and methods of their preparation

13. 7432394 - Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines

14. 7371888 - α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents

15. 7323480 - Substituted triazoles as modulators of PPAR and methods of their preparation